Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment Efficacy and Outcome of Sofosbuvir/Velpatasvir in Hepatitis C Virus Infection Among Adolescents and Young Adults
TCTR20230610001Unknown
- Sponsor
- Research and Development Institute
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of sofosbuvir + velpatasvir in hepatitis C virus infection, sponsored by Research and Development Institute. Primary endpoint: Treatment efficacy. Status: unknown.
02
Drugs
sofosbuvir + velpatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on TCTR20230610001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230610001.